In July, the editors from AACR's 10 peer-reviewed journals highlighted research on AI-driven molecular mapping of pancreatic cancer evolution,...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
The AACR, The Mark Foundation, Lustgarten Foundation, Break Through Cancer, and Tina’s Wish will explore early detection approaches for...
The countdown to the new year is nearly upon us, but no need to count down to the last...
New insights into the neurologic and physiologic impact of chronic stress on ovarian cancer were presented at two recent...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...